Research Output
Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
  The incidence of hetero-intermediate glycopeptide
susceptibility among Staphylococcus aureus
isolates in Malta, a country with a high incidence
of methicillin resistance, was studied by screening
454 non-repetitive S. aureus isolates on teicoplanin-
supplemented agar plates, followed by Etests
and genotypic studies. All strains were susceptible
to vancomycin, but four (0.88%) exhibited
teicoplanin MICs of > 12 mg⁄ L. High methicillinresistant
S. aureus endemicity was not an accurate
predictor of the emergence of non-susceptibility
to glycopeptides.

  • Type:

    Article

  • Date:

    30 November 2004

  • Publication Status:

    Published

  • Publisher

    Wiley

  • DOI:

    10.1111/j.1469-0691.2005.01110.x

  • ISSN:

    1198-743X

  • Library of Congress:

    QR Microbiology

  • Dewey Decimal Classification:

    579 Microorganisms, fungi & algae

Citation

Borg, M. A., Zerafa, R., Morrison, D. & Cuschieri, P. (2004). Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals. Clinical Microbiology and Infection. 11, 405-407. doi:10.1111/j.1469-0691.2005.01110.x. ISSN 1198-743X

Authors

Keywords

h-GISA; Malta; resistance, Staphylococcus aureus; teicoplanin; vancomycin;

Monthly Views:

Available Documents